Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-962-5136Fax+1 919-962-4421
Education & Training
- UNC Gillings School of Global Public HealthMSCR, Clinical Research, 2013 - 2016
- Duke University HospitalFellowship, Allergy and Immunology, 2008 - 2013
- Duke University HospitalFellowship, Pediatric Rheumatology, 2008 - 2013
- Vanderbilt University Medical CenterResidency, Pediatrics, 2005 - 2008
- Mercer University School of MedicineClass of 2005
Certifications & Licensure
- NC State Medical License 2008 - 2025
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatric Rheumatology
Publications & Presentations
PubMed
- Overlapping Clinical Phenotypes in Patients with Primary Ciliary Dyskinesia or Activated Phosphoinositide 3-Kinase Delta Syndrome.Adam J Shapiro, Eveline Y Wu, Deborah J Morris-Rosendahl, Kenneth N Olivier, Sharon D Dell
The Journal of Pediatrics. 2025-02-06 - TEMPORARY REMOVAL: EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO).Yongdong Zhao, Melissa S Oliver, Anja Schnabel, Eveline Y Wu, Zhaoyi Wang
Annals of the Rheumatic Diseases. 2025-01-30 - Secreted PD-L1 alleviates inflammatory arthritis in mice through local and systemic AAV gene therapy.Wenjun Li, Junjiang Sun, Susi Feng, Ariana La Rosa, Panli Zhang
Frontiers in Immunology. 2025-01-01
Journal Articles
- Review and Feature Article Eosinophilic Granulomatosis with Polyangiitis: Clinical Pathology Conference and ReviewRonald J Falk, Eveline Y Wu, Michelle L Hernandez, ScienceDirect
- Management of vasculitic glomerulonephritisWu EY, Pendergraft III WF, Nachman PH, Curr Treatm Opt Rheumatol, 6/2016
Other
- Type III hereditary angioedemaWu E, Frank MM
http://www.uptodate.com/contents/type-iii-hereditary-angioedema
UpToDate, Wolters Kluwer Health - 2012-07-19
Press Mentions
- Pharming Announces US FDA Approval of Joenja® (Leniolisib) as the First and Only Treatment Indicated for APDSMarch 24th, 2023
- The 2020 ACR Review Course: Key Issues Rheumatologists FaceDecember 17th, 2020
- Researchers Seek ANCA-Associated Vasculitis Subtype MarkersOctober 19th, 2020
Professional Memberships
- Member
- Member
- Childhood Rheumatology and Rheumatology Research AllianceMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: